BLOG | Consulting | Market Access 2026 Oncology Market Access Trends The oncology access landscape is increasingly shaped by a dynamic “tug of war” between payer-driven cost controls...
Read More
BLOG | Consulting | Pricing and Policy Strategy Implications of the IRA’s Maximum Fair Price (MFP) Negotiations The Inflation Reduction Act created Maximum Fair Price (MFP), a pathway...
Read More
BLOG | Consulting | Pricing and Policy Strategy 340B Drug Discount Program The 340B drug discount program was created in 1992 to lower outpatient drug costs for healthcare...
Read More
BLOG | Medical Communications The Human Dimensions of Cancer Care Deserving Your Attention Explore Our Insights
Read More
BLOG | Medica Communications Gut Check: Aligning Ambitions and Realities in the Competitive World of Gastroenterology Brand Promotion Explore Our Insights
Read More
BLOG | Medical Communications Beyond Blood Sugar: Embracing Complexity in Diabetes Care Explore Our Insights
Read More
BLOG | Medical Communications 5 Must-Do Med Comms Actions to Close 2025 Strong and Set a Foundation for 2026 Explore Our Insights
Read More
BLOG | Advertising 5 Common Mistakes to Avoid with Omnichannel Marketing Explore Our Insights
Read More
BLOG | Medical Communications Top Challenges and Goals in Oncology Branding: What Pharma & Biotech Teams Need Now Explore Our Insights
Read More
BLOG | Medical Communications Elevate Your Impact: The 7-Point Checklist for High-Stakes Scientific Communications Explore Our Insights
Read More
